0 results available. Select is focused ,type to refine list, press Down to open the menu,
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company’s lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides c...
The following section summarizes insights on Nutriband Inc's P/S % of 3 Year Avg P/S:
We've identified the following companies as similar to Nutriband Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to P/S % of 3 Year Avg P/S in the valuation category include:
Price / LTM Sales as a percentage of three-year quarterly average.
The chart above depicts the distribution of p/s % of 3 year avg p/s for companies operating in the Healthcare sector in the Developed economic region. Over 1,960 companies were considered in this analysis, and 1,884 had meaningful values. The average p/s % of 3 year avg p/s of companies in the sector is 86.6% with a standard deviation of 78.9%.
Nutriband Inc's P/S % of 3 Year Avg P/S of 175.4% ranks in the 90.1% percentile for the sector. The following table provides additional summary stats:
Economic Risk Region | Developed |
Total Constituents | 1,962 |
Included Constituents | 1,884 |
Min | 0.1% |
Max | 495.3% |
Median | 71.3% |
Mean | 86.6% |
Standard Deviation | 78.9% |
You can find companies with similar p/s % of 3 year avg p/s using this stock screener.